Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice

The timing of vaccine availability is essential for an effective response to pandemic influenza. In 2009, vaccine became available after the disease peak, and this has motivated the development of next generation vaccine technologies for more rapid responses. The SAM(®) vaccine platform, now in pre-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hekele, Armin, Bertholet, Sylvie, Archer, Jacob, Gibson, Daniel G, Palladino, Giuseppe, Brito, Luis A, Otten, Gillis R, Brazzoli, Michela, Buccato, Scilla, Bonci, Alessandra, Casini, Daniele, Maione, Domenico, Qi, Zhi-Qing, Gill, John E, Caiazza, Nicky C, Urano, Jun, Hubby, Bolyn, Gao, George F, Shu, Yuelong, De Gregorio, Ennio, Mandl, Christian W, Mason, Peter W, Settembre, Ethan C, Ulmer, Jeffrey B, Craig Venter, J, Dormitzer, Philip R, Rappuoli, Rino, Geall, Andrew J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821287/
https://ncbi.nlm.nih.gov/pubmed/26038486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2013.54
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados